🇰🇷 RYZNEUTA in South Korea

RYZNEUTA (EFBEMALENOGRASTIM ALFA-VUXW) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

RYZNEUTA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is RYZNEUTA approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for RYZNEUTA in South Korea?

EVIVE BIOTECHNOLOGY is the originator. The local marketing authorisation holder may differ — check the official source linked above.